Bhanu K. Sadasivan, PhD - McDermott Will & Emery

Overview


Bhanu Sadasivan focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software.

Show More

Results


  • Representing Alnylam in litigation over patents covering lipids and lipid nanoparticles
  • Representing Natera in litigation over patents covering methods of preparing DNA
  • Represented 23andMe in litigation over a patent covering a method of finding relative relationships
  • Represented Quidel in a patent litigation over lateral flow assay method
  • Represented Amgen in a patent litigation matter over novel antibody therapeutics for the treatment of high LDL-cholesterol (Amgen v. Sanofi, et al., (D. Delaware))

Show More

Recognitions


  • The Best Lawyers in America, Patent Litigation, 2024
  • Daily Journal, Top Intellectual Property Lawyer, 2023
  • IAM Patent 1000, The World’s Leading Patent Practitioners, 2022 to 2024

Show More

Community


  • Asian Law Alliance, board member and previous board president

Credentials


Education
University of California – Berkeley School of Law, JD
Yale University, PhD, Immunology
All India Institute of Medical Sciences, MS, Immunology, with honors
All India Institute of Medical Sciences, BSc, Human Biology, with honors

Admissions
California

Show More